3834 |
1D4J |
PDB NFT |
HIV-1 protease in complex with the inhibitor MSL370 |
>1d4j_A mol:protein length:99 HIV-1 PROTEASE
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
>1d4j_B mol:protein length:99 HIV-1 PROTEASE
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF |
3834 |
HLA04010 DRB1*04:82 |
HLA NFT |
DRB1*04:82 |
>HLA:HLA04010 DRB1*04:82 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPVAESWNSQKDILEDRRAAVDTYCRHNYGVGESFTVQRR |
3835 |
HLA04011 DRB1*08:01:05 |
HLA NFT |
DRB1*08:01:05 |
>HLA:HLA04011 DRB1*08:01:05 89 bp RFLEYSTGECYFFNGTERVRFLDRYFYNQEEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDFLEDRRALVDTYCRHNYGVGESFTVQRR |
3835 |
1D4K |
PDB NFT |
HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR |
>1d4k_A mol:protein length:99 HIV-1 PROTEASE
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF
>1d4k_B mol:protein length:99 HIV-1 PROTEASE
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF |
3835 |
Q4X0A5 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase B |
>sp|Q4X0A5|ABNB_ASPFU Probable arabinan endo-1,5-alpha-L-arabinosidase B OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) OX=330879 GN=abnB PE=3 SV=2 MTVLVALFCLVTWTLCTRIPQYSTQGTQQPQQPEKTPHPHPQPEDAFPPTHATDLKIHDPSIIHVDGTYYSYSVGRHIRIHQAPSLDGPWERTGAVLNADSVIPKGDRKAPWAPQTVHHNDTYYCFYAVSNSGCRDSAIGVATSKSPGPGGWTDHGLLVQSGTGKGSDEHPFTSSNTIDPSVFVGEDGHGYLTFGSFWSGIWQVPLDESLLSVAGDTSSEARQLVYMEKAPLPASKHPNPLCREPSGARPIEGSFLSYHEPWYYLWFSYGKCCKFDTKNLPPPGREYSIRVGRSKSPRGPFVDKQGRDLANGGGEIVYASNRDVYAPGGQGVLTEKSGDILYYHYCRYPVIQEIEVDADLTVNKSTSYDFWV |
3836 |
Q2UI74 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase B |
>sp|Q2UI74|ABNB_ASPOR Probable arabinan endo-1,5-alpha-L-arabinosidase B OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=abnB PE=3 SV=1 MVLVATLFSLFTVSLCRSIPRSSPSSSPYTQATDLKIHDPTVINANGAYYAYGVGEHIVIHQAPGLAGPWKQIGSVLDKDSIIPKGDRAKPWAPTTIEVKGTFYCYYSVSNAGCRDSAIGVATSQSPGPGGWTDHGAIVQSGTGQGSDEHPFNEVNAIDPAVLVTGDKGHLVFGSYWSGIWQVPLNEDFSSVGNTTGLNAHHLAKHPKTERVNSQDQNPDPLCRDSSGRRPVEGAYISYHAPYYYLWLSWGQCCDYDPNNLPPSGEEYSIRVGRSESPHGPFVDKQGKELTQGGGELIYGSNNDVYAPGGQGVITVETGDILYYHYSLYRYSTHSLYTFANLDFNQGCTLFIQ |
3836 |
1D4L |
PDB NFT |
HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR |
>1d4l_A mol:protein length:99 HIV-1 PROTEASE
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF
>1d4l_B mol:protein length:99 HIV-1 PROTEASE
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF |
3836 |
HLA04012 DRB1*04:05:07 |
HLA NFT |
DRB1*04:05:07 |
>HLA:HLA04012 DRB1*04:05:07 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRR |
3837 |
HLA04013 B*44:03:07 |
HLA NFT |
B*44:03:07 |
>HLA:HLA04013 B*44:03:07 273 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQDAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVESLRRYLENGKETLQRADPPKTHVTHHPISDHEVTLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW |
3837 |
1D4M |
PDB NFT |
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION |
>1d4m_1 mol:protein length:299 PROTEIN (COXSACKIEVIRUS A9)
GDVEEAIERAVVHVADTMRSGPSNSASVPALTAVETGHTSQVTPSDTMQTRHVKNYHSRSESTVENFLGRSACVYMEEYKTTDNDVNKKFVAWPINTKQMVQMRRKLEMFTYLRFDMEVTFVITSRQDPGTTLAQDMPVLTHQIMYVPPGGPIPAKVDDYAWQTSTNPSIFWTEGNAPARMSIPFISIGNAYSNFYDGWSNFDQRGSYGYNTLNNLGHIYVRHVSGSSPHPITSTIRVYFKPKHTRAWVPRPPRLCQYKKAFSVDFTPTPITDTRKDINTVTTVAQSRRRGDMSTLNTH
>1d4m_2 mol:protein length:261 PROTEIN (COXSACKIEVIRUS A9)
SPTVEECGYSDRVRSITLGNSTITTQECANVVVGYGRWPTYLRDDEATAEDQPTQPDVATCRFYTLDSIKWEKGSVGWWWKFPEALSDMGLFGQNMQYHYLGRAGYTIHVQCNASKFHQGCLLVVCVPEAEMGGAVVGQAFSATAMANGDKAYEFTSATQSDQTKVQTAIHNAGMGVGVGNLTIYPHQWINLRTNNSATIVMPYINSVPMDNMFRHYNFTLMVIPFVKLDYADTASTYVPITVTVAPMCAEYNGLRLAQAQ
>1d4m_3 mol:protein length:238 PROTEIN (COXSACKIEVIRUS A9)
GLPTMNTPGSTQFLTSDDFQSPCALPQFDVTPSMNIPGEVKNLMEIAEVDSVVPVNNVQDTTDQMEMFRIPVTINAPLQQQVFGLRLQPGLDSVFKHTLLGEILNYYAHWSGSMKLTFVFCGSAMATGKFLIAYSPPGANPPKTRKDAMLGTHIIWDIGLQSSCVLCVPWISQTHYRLVQQDEYTSAGYVTCWYQTGMIVPPGTPNSSSIMCFASACNDFSVRMLRDTPFISQDNKLQ
>1d4m_4 mol:protein length:68 PROTEIN (COXSACKIEVIRUS A9)
GAQVSTQKTGAHETSLSAAGNSIIHYTNINYYKDAASNSANRQDFTQDPSKFTEPVKDVMIKSLPALN |
3837 |
Q0CY27 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase B |
>sp|Q0CY27|ABNB_ASPTN Probable arabinan endo-1,5-alpha-L-arabinosidase B OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=abnB PE=3 SV=2 MRRIIKILVVVAVLYLAIIFLFANTRRVVPIHRQTPFPPTHPADLKIHDPSILKVGDKYYSYSVGPRIVIHEAPTLSGPWKKTGHVLDKDSIIPKGDRKAPWAPTTIEVAGTYYCYYAVSQSGCRNSAIGVATSQSPGPGGWTDHGAIIHTGTGPGSDSAPFDRSNAIDASVILTPDGNGYLNFGSYWTGIWQVPLNADLVSISDVSTNAARHLAYEPHAFSPGGKNPNPLCGDRSGSHPIEGAFVSYRAPFYYLWFSWGKCCKYNPKALPPRGKEYQIRVGRSTHPQGPFVDRQGVDLIEGGGEVVYGSNRDVYAPGGQGVLTDEGTDILYYHYLNKTVSLDFWEARLGYNPLIYIDGWPVAQ |
3838 |
Q5AZC8 |
AF NFT |
Arabinan endo-1,5-alpha-L-arabinosidase B |
>sp|Q5AZC8|ABNB_EMENI Arabinan endo-1,5-alpha-L-arabinosidase B OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=abnB PE=2 SV=1 MAVIFVLFFLVSMALSARIRPSFNGTALSGTSNKHPFEPGPNTIFREEVPPSAAASGFPSAHGTELRTHDPSIIKVGSIYYSYSVGPSITIHQAFSLDGPWTEVGALLSGESVIKKGDRKAPWAANTIYINGRYYCYYSVSNSGCRDSAIGVASSAFPGPGEWTDHGLIIQSGTGEGSDVFPLNQSNTIDPNVFVDGDGTAYLNFGSFWTGLWQVPLEEELVTVKGLQDGTLDAVHLAAEPGKVWRSKLANSKAKTVSTSKTGSPICGDPTGGHPIEGGFMAYHAPYYYMWFSWGRCCEFKDPAMRSNGKEYRIRVGRSTSARGPFVDKQGIDLVDGGGETVYGSNGDVFAPGGQGILTDEFGDILYYHYLNSSVSYDFADARLGYNRLEYVDGWPVAVY |
3838 |
1D4N |
PDB NFT |
HUMAN SERUM TRANSFERRIN |
>1d4n_A mol:protein length:329 TRANSFERRIN
DKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKESTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTC |
3838 |
HLA04014 B*44:81 |
HLA NFT |
B*44:81 |
>HLA:HLA04014 B*44:81 273 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRNEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQDAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVESLRRYLENGKETLQRADPPKTHVTHHPISDHEVTLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW |
3839 |
HLA04015 B*51:78:01 |
HLA NFT |
B*51:78:01 |
>HLA:HLA04015 B*51:78:01 362 bp MRVTAPRTVLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRENLRTALRYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRADPPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDVSLTA |
3839 |
1D4O |
PDB NFT |
CRYSTAL STRUCTURE OF TRANSHYDROGENASE DOMAIN III AT 1.2 ANGSTROMS RESOLUTION |
>1d4o_A mol:protein length:184 NADP(H) TRANSHYDROGENASE
MEISGTHTEINLDNAIDMIREANSIIITPGYGLCAAKAQYPIADLVKMLSEQGKKVRFGIHPVAGRMPGQLNVLLAEAGVPYDIVLEMDEINHDFPDTDLVLVIGANDTVNSAAQEDPNSIIAGMPVLEVWKSKQVIVMKRSLGVGYAAVDNPIFYKPNTAMLLGDAKKTCDALQAKVRESYQK |
3839 |
A1DHW8 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase B |
>sp|A1DHW8|ABNB_NEOFI Probable arabinan endo-1,5-alpha-L-arabinosidase B OS=Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) OX=331117 GN=abnB PE=3 SV=2 MAVLVALFCLVTWALCTRIPQYSTQGTQQLQQPEKTPHPHPRPEDPFPPTHAADFKIHDPSIIHVDGTYYSYSVGKHIRIHQAPSLDGPWKRTGTVLDADSVIPKGDRKAPWAPQTVHHGDTYYCFYAVSNSGCRDSAIGVATSKSPGPGGWTDHGLLVQSGTGKGSDEHPFASSNTIDPSVFVGEDGHGYLMFGSFWSGIWQVPLDETLLSVAGDTRSEARQLVYMEKAPLPASKHPNPLCREPSGARPIEGSFLSYHEPWYYLWFSYGKCCKFDTKNLPPPGREYSIRVGRSKSPRGPFVDKQGRDLANGGGEIVYASNRDVYAPGGQAVLTEKSGDILYYHYCRYPAVQETEVDADLTVNKSTSYDFWV |
3840 |
A1CN18 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|A1CN18|ABNC_ASPCL Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) OX=344612 GN=abnC PE=3 SV=1 MFVYTLIFLFLAAANAYSNPGPCSGNCWTHDPGLYQRKSDGKYFLFATGGGIHISSADDLAGPWTDDGFVLPDGSSIDLDGQNNLWAPDLHYRDGTYYLYYSVSALGSQNSAIGVATSETLEAGSWTDHGSTGVTSTPNSPYNTIDGNWIAVGDKQYLNFGSYWQNLFQVELADGLKVKEGATPHQLSYNASGIHRQEAAFMFERNSYFYLTFSGGVALGYNATWPAQGEEYHINVCRSTSATGGFVDKNGVSCLNSGGSLLLASHGFVYGPGGQGILEDRNKELVLYYHYADTRIGKAVEDYQFGWNQLKWENDWPSV |
3840 |
1D4P |
PDB NFT |
CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5-AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR |
>1d4p_A mol:protein length:36 ALPHA-THROMBIN
TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR
>1d4p_B mol:protein length:259 ALPHA-THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE
>1d4p_H mol:protein length:12 HIRUGEN
GDFEEIPEEYLQ |
3840 |
HLA04016 C*02:29 |
HLA NFT |
C*02:29 |
>HLA:HLA04016 C*02:29 366 bp MRVMAPRTLLLLLSGALALTETWACSHSMRYFYTAVSRPSRGEPHFIAVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVNLRKLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQWRAYLEGECVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPTEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHERLPEPLTLRWEPSSQPTIPIVGIVAGLAVLAVLAVLGAVVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA |
3841 |
HLA04017 B*55:02:04 |
HLA NFT |
B*55:02:04 |
>HLA:HLA04017 B*55:02:04 273 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTWQTMYGCDLGPDGRLLRGHNQLAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW |
3841 |
1D4R |
PDB NFT |
29-mer fragment of human srp rna helix 6 |
>1d4r_A mol:na length:29 29-MER OF MODIFIED SRP RNA HELIX 6
GGUGACCUCCCGGGAGCGGGGGACCACUA
>1d4r_B mol:na length:29 29-MER OF MODIFIED SRP RNA HELIX 6
GGUGACCUCCCGGGAGCGGGGGACCACUA
>1d4r_C mol:na length:29 29-MER OF MODIFIED SRP RNA HELIX 6
GGUGACCUCCCGGGAGCGGGGGACCACUA |
3841 |
B0YDT3 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|B0YDT3|ABNC_ASPFC Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Neosartorya fumigata (strain CEA10 / CBS 144.89 / FGSC A1163) OX=451804 GN=abnC PE=3 SV=2 MYLYTLILLFLASANVNAYANPGACSGNCWTHDPGLYQRKSDGKYFRFATGGGIHIASADSLEGPWTDDGYVLPSGSIIDLDGKTNLWAPDLHYHDGTYYLYYAVSSLGSQNSAIGVATSKTMEAGSWTDHGTTGIESTPSSPYNTIDANWIAVGGNQYVNFGSYWNNLFQVEMENGLKVKSGATPHQIAYNASGIHRQEAAFMFERNNYFYLTFSGGIALGYNDTWPAPGEEYFIAVCRSTSATGGFVDKNGVSCLNSGGSLLLSSHDFVYGPGGQGILQDSSKGFVLYYHYADTRIGKAVEDYQFGWNQLKWENDWPSV |
3842 |
B8NMD3 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|B8NMD3|ABNC_ASPFN Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=abnC PE=3 SV=2 MLSFLAALSLPLALVNAYANPGTCNGNCWAHDPGLWKHDDGRYFLFSTGNGIHISSAPSLQGPWTEVGYALPDGSSINHDGNKNLWAPDVHKGDDGKYYMYYSVSTLGSQNSVIGVASSTTMEPGSWTDHGSTGLSSDGSQGYNTIDANWIKIGDQQVLNFGSYWQGLYQIDLAGPLKIGTAAPVNIAYNATGQHAIEASFLYQQNGFYYLFFSSGKANGYDTSFPAQGEEYRINVCRSSTGRGDFVDKNGVSCLQSGGTTVLASHDNVYGPGGQGVLEDNGAVLYYHYAPRNGDLSVSSYQFGWNRLNWVDGWPTV |
3842 |
1D4S |
PDB NFT |
HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX |
>1d4s_A mol:protein length:99 PROTEIN (HIV-1 PROTEASE)
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF
>1d4s_B mol:protein length:99 PROTEIN (HIV-1 PROTEASE)
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPFNVIGRNLLTQIGCTLNF |
3842 |
HLA04018 A*02:191 |
HLA NFT |
A*02:191 |
>HLA:HLA04018 A*02:191 273 bp SHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMCGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQWRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRW |
3843 |
HLA04019 C*01:29 |
HLA NFT |
C*01:29 |
>HLA:HLA04019 C*01:29 181 bp SHSMKYFFTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEAGSHTLQWMCGCDLGPDGRLLRGYDQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVECLRRYLENGKETLQRA |
3843 |
1D4T |
PDB NFT |
CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE |
>1d4t_A mol:protein length:104 T CELL SIGNAL TRANSDUCTION MOLECULE SAP
MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEK
>1d4t_B mol:protein length:11 SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE
KSLTIYAQVQK |
3843 |
Q4W930 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|Q4W930|ABNC_ASPFU Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) OX=330879 GN=abnC PE=3 SV=2 MYLYTLILLFLASANVNAYANPGACSGNCWTHDPGLYQRKSDGKYFRFATGGGIHIASADSLEGPWTDDGYVLPSGSIIDLDGKTNLWAPDLHYHDGTYYLYYAVSSLGSQNSATGVATSKTMEAGSWTDHGTTGIESTPSSPYNTIDANWIAVGGTQYVNFGSYWNNLFQVEMENGLKVKSGATPHQIAYNASGIHRQEAAFMFERNNYFYLTFSGGIALGYNDTWPAPGEEYFIAVCRSTSATGGFVDKNGVSCLNSGGSLLLSSHDFVYGPGGQGILQDSSKGFVLYYHYADTRIGKAVEDYQFGWNQLKWENDWPSV |
3844 |
A5AAG2 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|A5AAG2|ABNC_ASPNC Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Aspergillus niger (strain CBS 513.88 / FGSC A1513) OX=425011 GN=abnC PE=3 SV=1 MLSFVLLLCVALVNAYSDPGACSGTCWAHDPNVIRRVSDGTYFRFSTGGGVHISSASAITGPWTDLGYALPNGSIVTVGNASNLWAPDVHYVDGTYYMYYASSTLGSRDSTIGVATSTTLEADSWTDHGEIGVTSSSSTPYNAIDPNWITIGSTPYLQFGSYWQGLYQVEMTDSLSASSSTPTNLAYNASGNHAIEASYLYEYGGYYYLTFSSGKAQGYTTSLPAQGDEYRIVVCRSKTGTGNFVDKDGVSCLNSGGTTVLASHDYVYGPGGQGIINTTSHGIVVYYHYANKNIGLAVDDYQFGWNTLTWTDGWPVVA |
3844 |
1D4U |
PDB NFT |
INTERACTIONS OF HUMAN NUCLEOTIDE EXCISION REPAIR PROTEIN XPA WITH RPA70 AND DNA: CHEMICAL SHIFT MAPPING AND 15N NMR RELAXATION STUDIES |
>1d4u_A mol:protein length:111 NUCLEOTIDE EXCISION REPAIR PROTEIN XPA (XPA-MBD)
MEFDYVICEECGKEFMDSYLMDHFDLPTCDDCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQ |
3844 |
HLA04020 C*01:30 |
HLA NFT |
C*01:30 |
>HLA:HLA04020 C*01:30 366 bp MRVMAPRTLILLLSGALALTETWACSHSMKYFFTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEAGSHTLQWMCGCDLGPDGRLLRGYDQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRHLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVMVPSGEEQRYTCHVQHEGLPEPLTLRWEPSSQPTIPIVGIVAGLAVLAVLAVLGAVVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA |
3845 |
HLA04021 C*07:75 |
HLA NFT |
C*07:75 |
>HLA:HLA04021 C*07:75 366 bp MRVMAPRALLLLLSGGLALTETWACSHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQADRVSLRNLRGHYNQSEDGSHTLQRMSGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKLEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRAEPPKTHVTHHPLSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHMQHEGLQEPLTLSWEPSSQPTIPIMGIVAGLAVLVVLAVLGAVVTAMMCRRKSSGGKGGSCSQAACSNSAQGSDESLITCKA |
3845 |
1D4V |
PDB NFT |
Crystal structure of trail-DR5 complex |
>1d4v_B mol:protein length:163 TNF-RELATED APOPTOSIS INDUCING LIGAND
PQRVAAHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFELKENDRIFVSVTNEHLIDMDHEASFFGAFLVG
>1d4v_A mol:protein length:117 DEATH RECEPTOR 5
PQQKRSSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTRNTVCQCEEGTFREEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECVHKESGD |
3845 |
Q2U1X8 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|Q2U1X8|ABNC_ASPOR Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=abnC PE=3 SV=1 MLSFLAALSLPLALVNAYANPGTCNGNCWAHDPGLWKHDDGRYFLFSTGNGIHISSAPSLQGPWTEVGYALPDGSSINHDGNKNLWAPDVHKGDDGKYYMYYSVSTLGSQNSVIGVASSTTMEPGSWTDHGSTGLSSDGSQGYNTIDANWIKIGDQQVLNFGSYWQGLYQIDLAGPLKIGTAAPVNIAYNATGQHAIEASFLYQQNGFYYLFFSSGKANGYDTSFPAQGEEYRINVCRSSTGRGDFVDKNGVSCLQSGGTTVLASHDNVYGPGGQGVLEDNGAVLYYHYAPRNGDLSVSSYQFGWNRLNWVDGWPTV |
3846 |
Q0CRJ6 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|Q0CRJ6|ABNC_ASPTN Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=abnC PE=3 SV=1 MYRSTLLFLFIALVNAFANPGPCTGDCWTHDPGLYQRKSDGRYFRFATGGGIHISSAPAIVGPWEDNGFALPNGSKINHAGNDNLWAPDVHYQENTKKYYMYYSVSVLGKKDSVIGVASSDTMEVGSWTDHGSIGLNTSNNPPYNTIDANWIRIDGAPALNFGSYWQGIFQVPLKNPFELAEIAPHQIAWNASLNHRIEAAFEFKHGNYYYLTFSSGLGGNYDVNLPAQGEEYSIHVCRSEGGRNNFVDKSGRSCRESGGTTLLASHGNVYAPGGQGIVEDKNLGQVLYYHYADKTKGLAKTDYQFGWNRLNWVDGWPSV |
3846 |
1D4W |
PDB NFT |
CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE |
>1d4w_A mol:protein length:104 T CELL SIGNAL TRANSDUCTION MOLECULE SAP
MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEK
>1d4w_B mol:protein length:104 T CELL SIGNAL TRANSDUCTION MOLECULE SAP
MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEK
>1d4w_C mol:protein length:11 SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE
KSLTIYAQVQK
>1d4w_D mol:protein length:11 SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE
KSLTIYAQVQK |
3846 |
HLA04022 B*44:82 |
HLA NFT |
B*44:82 |
>HLA:HLA04022 B*44:82 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHTIQRMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVESLRRYLENGKETLQRA |
3847 |
HLA04023 B*15:18:03 |
HLA NFT |
B*15:18:03 |
>HLA:HLA04023 B*15:18:03 181 bp SHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQICKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
3847 |
1D4X |
PDB NFT |
Crystal Structure of Caenorhabditis Elegans Mg-ATP Actin Complexed with Human Gelsolin Segment 1 at 1.75 A resolution. |
>1d4x_A mol:protein length:375 C. ELEGANS ACTIN 1/3
CDDEVAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGVVLDSGDGVTHTVPIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSYELPDGQVITVGNERFRCPEAMFQPSFLGMESAGIHETSYNSIMKCDIDIRKDLYANTVLSGGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRKCF
>1d4x_G mol:protein length:126 GELSOLIN
MVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFK |
3847 |
Q5AUM3 |
AF NFT |
Arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|Q5AUM3|ABNC_EMENI Arabinan endo-1,5-alpha-L-arabinosidase C OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=abnC PE=2 SV=1 MKLALSLFLLSGSLAQYSNPGACSGDCWGHDPGFYQRVSDGRYYRFSTGGGIQIHASDNLEGPWEAVGEALPGGSVVDHAGSTNLWAPDIHYEASTNLYYMYYSVSTLGSRDSVIGVATSPNLQPNWTDHGALFRSQAGGNYNAIDANWASIGGSPILTFGSYWNGIHQLPLAGPLSLADGATPTQIAYNSSGNHAIEAGFVFYRRGWYYLTFSSGRAGSYDTNPPATGEEYRIVVCRSASGTGDFVDKSGRSCLTDNGGTTILASHGNVYGPGGQGVFEDRTRGWVLYYHYANPDIGLSTGQYQFGWNVLQWADGWPSV |
3848 |
A1DKY5 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase C |
>sp|A1DKY5|ABNC_NEOFI Probable arabinan endo-1,5-alpha-L-arabinosidase C OS=Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) OX=331117 GN=abnC PE=3 SV=1 MYLYTLILLFLASVNVNAYADPGACSGNCWTHDPGLYQRKSDGKYFRFATGGGIHIASADSLEGPWTDDGYVLPNGSIIDLNGKNNLWAPDLHYRDGTYYLYYAVSSLGSQNSAIGVATSKTMEAGSWTDHGTTGIESTPASPYNAIDANWIAVGGTQYANFGSYWNNLFQVEMTNGLKVKSGATPHQIAYNASGIHRQEAAFMFERNDYFYLTFSGGIALGYNDTWPAPGEEYFISVCRSTSATGGFVDKNGVSCLNSGGTLLLASHGFVYGPGGQGILKDSSKGFVLYYHYADTRIGKAVEDYQFGWNQLKWENDWPSV |
3848 |
1D4Y |
PDB NFT |
HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX |
>1d4y_A mol:protein length:99 PROTEIN (HIV-1 PROTEASE)
PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
>1d4y_B mol:protein length:99 PROTEIN (HIV-1 PROTEASE)
PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF |
3848 |
HLA04024 B*56:26 |
HLA NFT |
B*56:26 |
>HLA:HLA04024 B*56:26 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQNEAGSHTWQTMYGCDLGPDGRLLRGHNQLAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
3849 |
HLA04025 B*58:24 |
HLA NFT |
B*58:24 |
>HLA:HLA04025 B*58:24 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDGETRNMKASAQTYRENLRIALRYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQSAYDRKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
3849 |
1D4Z |
PDB NFT |
CRYSTAL STRUCTURE OF CHEY-95IV, A HYPERACTIVE CHEY MUTANT |
>1d4z_A mol:protein length:128 CHEMOTAXIS PROTEIN CHEY
ADKELKFLVVDDFSTMRRIVRNLLKELGFNNVEEAEDGVDALNKLQAGGYGFVISDWNMPNMDGLELLKTIRADGAMSALPVLMVTAEAKKENVIAAAQAGASGYVVKPFTAATLEEKLNKIFEKLGM |
3849 |
Q5B8T6 |
AF NFT |
Probable arabinan endo-1,5-alpha-L-arabinosidase D |
>sp|Q5B8T6|ABND_EMENI Probable arabinan endo-1,5-alpha-L-arabinosidase D OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=abnD PE=2 SV=2 MVHITLPGLLLCLCLYLSVAPANPLNAHARVSDTTAFPLPNEGHVVAHDPSIVRHHEHFYLFKGGIHIPVFRASNLSGPWERLGTVLNGPSLVQKQNQRRPWAPMVTQWKNRFYCFYSISQNGKRNSAIGVASSDSVEPGGWTDHGPLINTGHGPGSGVYPFNVSNAIDPAFFADPITGQPYLQYGSYWKGIFQVPLAEDLLSVENATHPNTDHLVFLPKKKPKPNEGVFMSYRAPYYYAWFSHGQCCHFKTQGFPKEGNEYSIRVGRSTSVHGPFVDRDNKDLLNGGGSVVYGSNHGKVYAPGGLGVLPGANGEPDVLYYHYHNASIGFAQGDARLGWNYLDYVDGWPVPRAPSNPGNSLQPPSSVSLQIVAFLCLVILFTL |
3850 |
P33487 |
AF NFT |
Auxin-binding protein 1 |
>sp|P33487|ABP1_ARATH Auxin-binding protein 1 OS=Arabidopsis thaliana OX=3702 GN=ERABP1 PE=1 SV=1 MIVLSVGSASSSPIVVVFSVALLLFYFSETSLGAPCPINGLPIVRNISDLPQDNYGRPGLSHMTVAGSVLHGMKEVEIWLQTFAPGSETPIHRHSCEEVFVVLKGSGTLYLAETHGNFPGKPIEFPIFANSTIHIPINDAHQVKNTGHEDLQVLVIISRPPIKIFIYEDWFMPHTAARLKFPYYWDEQCIQESQKDEL |
3850 |
1D53 |
PDB NFT |
CRYSTAL STRUCTURE AT 1.5 ANGSTROMS RESOLUTION OF D(CGCICICG), AN OCTANUCLEOTIDE CONTAINING INOSINE, AND ITS COMPARISON WITH D(CGCG) AND D(CGCGCG) STRUCTURES |
>1d53_A mol:na length:2 DNA (5'-D(*CP*GP*CP*IP*CP*IP*CP*G)-3')
CG
>1d53_B mol:na length:2 DNA (5'-D(*CP*GP*CP*IP*CP*IP*CP*G)-3')
CG
>1d53_C mol:na length:4 DNA (5'-D(*CP*GP*CP*G)-3')
CGCG
>1d53_D mol:na length:4 DNA (5'-D(*CP*GP*CP*G)-3')
CGCG |
3850 |
HLA04027 B*14:12 |
HLA NFT |
B*14:12 |
>HLA:HLA04027 B*14:12 295 bp ALALTETWAGSHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQICKTNTQTDRESLRNLRGYYNQSEAGSHTLQWMYGCDVGPDGRLLRGYNQFAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLGAYLEGTCVEWLRRHLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVG |
3851 |
HLA04028 B*15:170 |
HLA NFT |
B*15:170 |
>HLA:HLA04028 B*15:170 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPKMAPRAPWIEQEGPEYWDRNTQISKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
3851 |
1D54 |
PDB NFT |
ANTHRACYCLINE BINDING TO DNA: HIGH RESOLUTION STRUCTURE OF D(TGTACA) COMPLEXED WITH 4'-EPIADRIAMYCIN |
>1d54_A mol:na length:6 DNA (5'-D(*TP*GP*TP*AP*CP*A)-3')
TGTACA |
3851 |
P13689 |
AF NFT |
Auxin-binding protein 1 |
>sp|P13689|ABP1_MAIZE Auxin-binding protein 1 OS=Zea mays OX=4577 GN=ABP1 PE=1 SV=1 MAPDLSELAAAAAARGAYLAGVGVAVLLAASFLPVAESSCVRDNSLVRDISQMPQSSYGIEGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLMGSSSLKYPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTAAVLKFPFVWDEDCFEAAKDEL |
3852 |
Q27905 |
AF NFT |
Probable antibacterial peptide polyprotein |
>sp|Q27905|ABP1_RIPCL Probable antibacterial peptide polyprotein OS=Riptortus clavatus OX=41704 PE=2 SV=1 MRSPRVIHLACVIAYIVAVEAGDKPVYLPRPTPPRPIHPRLAREVGWELEGQGLSPLSEAELLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSVAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRVASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEEEVLPEVRERGSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSVAEDLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDATLESELSPSSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEVLPEVRERRSPVDKGGYLPRPTPPRPVYRSRRDASLESELSPLSEAEGLPEVRERRSPGGQGGYLPRPTPRTPLCRSRRDANLDAEQSPVSEGVVLPEVR |
3852 |
1D56 |
PDB NFT |
ALTERNATIVE STRUCTURES FOR ALTERNATING POLY(DA-DT) TRACTS: THE STRUCTURE OF THE B-DNA DECAMER C-G-A-T-A-T-A-T-C-G |
>1d56_A mol:na length:10 DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3')
CGATATATCG
>1d56_B mol:na length:10 DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3')
CGATATATCG |
3852 |
HLA04029 DRB1*13:93 |
HLA NFT |
DRB1*13:93 |
>HLA:HLA04029 DRB1*13:93 89 bp RFLEYSTSECHFFNGTERVRFLDRYFHNQEENVRFDSDVGEFRAVTELGRPSAEYWNSQKDILEDERAAVDTYCRHNYGVVESFTVQRR |
3853 |
HLA04030 DRB1*11:01:11 |
HLA NFT |
DRB1*11:01:11 |
>HLA:HLA04030 DRB1*11:01:11 220 bp RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEFRAVTELGRPDEEYWNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVHPKVTVYPSKTQPLQHHNLLVCSVSGFYPGSIEVRWFRNGQEEKTGVVSTGLIHNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRARSESAQSKMLSGVGGFVLGLLFLGAGLFIYFRNQK |
3853 |
1D57 |
PDB NFT |
ALTERNATIVE STRUCTURES FOR ALTERNATING POLY(DA-DT) TRACTS: THE STRUCTURE OF THE B-DNA DECAMER C-G-A-T-A-T-A-T-C-G |
>1d57_A mol:na length:10 DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3')
CGATATATCG
>1d57_B mol:na length:10 DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3')
CGATATATCG |
3853 |
P38479 |
AF NFT |
Actin-binding protein |
>sp|P38479|ABP1_SACEX Actin-binding protein OS=Saccharomyces exiguus OX=34358 GN=ABP1 PE=3 SV=1 MALEPIDATTHSRDIEQEYQKVVRGTDNDTTWLIISPNTQKEYLPSSTGSSFSDFLQSFDETKVEYGIARVSPPGSDVGKIILVGWCPDSAPMKTRASFAANFGTIANSVLPGYHIQVTARDEDDLDEEELLTKISNAAGARYSIQAAGNSVPTSSASGSAPVKKVFTPSLAKKESEPKKSFVPPPVREEPVPVNVVKDNDADDWDEPEIKERNFETNPLSDNKPAYEPIGKIDLKKVIAEETAKEDPRLINRIDPSADIAHLKQESKIHRDNDLDNLLKQEKTSSPAVGGTKPPLVNLIFVEMIIVIRLYKVSRPEKSPAQLWAEKKMKQNQQSDSAQEEQKPVETKTEIEIGVDNSDEMKIGDLKSRFEKLGAETETEPEPPVQWETDSIPTVVKPQTFGQPAANSKPATQEVKKPFTPSNIGQRLPGMHTETPEHEEEDNDDDWGEDEDEPPKRNIPPPVMPARESAPQQPLPPRNTEPEPVEEGEEEEEEEEEEEEEAPAPSLPSRNAAPEPEPEQPQEEEEEEEAPAPSLPSRGSVPPPPPQRAVEPEEPAAEAPWATAEYDYEAGEDNELTFAENDKIINIEFVDDDWWLGELETTGQKGLFPSNYVVLGN |
3854 |
P49777 |
AF NFT |
ARS-binding protein 1 |
>sp|P49777|ABP1_SCHPO ARS-binding protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=abp1 PE=1 SV=2 MGKIKRRAITEHEKRALRHYFFQLQNRSGQQDLIEWFREKFGKDISQPSVSQILSSKYSYLDNTVEKPWDVKRNRPPKYPLLEAALFEWQVQQGDDATLSGETIKRAAAILWHKIPEYQDQPVPNFSNGWLEGFRKRHILHAINEQPTESVVLNNTEPPNDPLSRVYDVTRLTNINDIFTMQETGLFWKLVPNGTPEVEDIKGITRFKARITLTVCCNASGTERLPLWVIGYSQSPRVFRAANVKPEVMNFKWRSNGKASMTTAIMEEWLRWFDACMEGRKVILLIDSYTPHLRAVENIRNSGNDLRNTTVITLPSTSASISQPCSEGVIYALKACYRKHWVQYILEQNELGRNPYNTTNVLRAILWLVKAWTTDISPEIIENAFNLSGVLGLFNESAVTSRALDEMIHPLRELVSEFSVQAAMRIEDFISPSEENIVDSSEDIINQIASQYMDDRAFETDEEESTEFQITTKDAMKAIELLLNYEAQQPDGNPAITISLLNYQKLLEARGGNVNLSRLRST |
3854 |
1D58 |
PDB NFT |
THE MOLECULAR STRUCTURE OF A 4'-EPIADRIAMYCIN COMPLEX WITH D(TGATCA) AT 1.7 ANGSTROM RESOLUTION-COMPARISON WITH THE STRUCTURE OF 4'-EPIADRIAMYCIN D(TGTACA) AND D(CGATCG) COMPLEXES |
>1d58_A mol:na length:6 DNA (5'-D(*TP*GP*AP*TP*CP*A)-3')
TGATCA |
3854 |
HLA04031 DRB1*13:94:01 |
HLA NFT |
DRB1*13:94:01 |
>HLA:HLA04031 DRB1*13:94:01 89 bp RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDILEDKRAAVDNYCRHNYGVVESFTVQRR |
3855 |
HLA04032 DRB1*11:83 |
HLA NFT |
DRB1*11:83 |
>HLA:HLA04032 DRB1*11:83 89 bp RFLEYSTSECHFFNGTERVRYLDRYFHNQEENVRFDSDVGEYRAVTELGRPDEEYWNSQKDFLEDRRAAVDTYCRHNYGVVESFTVQRR |
3855 |
1D59 |
PDB NFT |
CRYSTAL STRUCTURE OF 4-STRANDED OXYTRICHA TELOMERIC DNA |
>1d59_A mol:na length:12 DNA (5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3')
GGGGTTTTGGGG
>1d59_B mol:na length:12 DNA (5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3')
GGGGTTTTGGGG
>1d59_C mol:na length:12 DNA (5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3')
GGGGTTTTGGGG
>1d59_D mol:na length:12 DNA (5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3')
GGGGTTTTGGGG |
3855 |
P33490 |
AF NFT |
Auxin-binding protein T85 |
>sp|P33490|ABP1_TOBAC Auxin-binding protein T85 OS=Nicotiana tabacum OX=4097 GN=T85 PE=3 SV=1 MARHVLVVVAVLLFATAEASQCSINGLPLVRNISELPQENYGRSGLSHTTIAGSVLHGMKEIEVWLQTFAPGSRTPIHRHSCEEIFVVLKGQGILYLTPSSHSKYPGNPQEFHIFPNSTFHIPVNDVHQVWNTGEHEDLQVLVVISRPPVKVFMYDDWSMPHTAAKLKFPYYWDEECYQTTSWKDEL |
3856 |
P15891 |
AF NFT |
Actin-binding protein |
>sp|P15891|ABP1_YEAST Actin-binding protein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ABP1 PE=1 SV=4 MALEPIDYTTHSREIDAEYLKIVRGSDPDTTWLIISPNAKKEYEPESTGSSFHDFLQLFDETKVQYGLARVSPPGSDVEKIIIIGWCPDSAPLKTRASFAANFAAVANNLFKGYHVQVTARDEDDLDENELLMKISNAAGARYSIQTSSKQQGKASTPPVKKSFTPSKSPAPVSKKEPVKTPSPAPAAKISSRVNDNNDDDDWNEPELKERDFDQAPLKPNQSSYKPIGKIDLQKVIAEEKAKEDPRLVQKPTAAGSKIDPSSDIANLKNESKLKRDSEFNSFLGTTKPPSMTESSLKNDDDKVIKGFRNEKSPAQLWAERKAKQNSGNAETKAEAPKPEVPEDEPEGEPDVKDLKSKFEGLAASEKEEEEMENKFAPPPKKSEPTIISPKPFSKPQEPVKAEEAEQPKTDYKKIGNPLPGMHIEADNEEEPEENDDDWDDDEDEAAQPPLPSRNVASGAPVQKEEPEQEEIAPSLPSRNSIPAPKQEEAPEQAPEEEIEEEAEEAAPQLPSRSSAAPPPPPRRATPEKKPKENPWATAEYDYDAAEDNELTFVENDKIINIEFVDDDWWLGELEKDGSKGLFPSNYVSLGN |
3856 |
1D5A |
PDB NFT |
CRYSTAL STRUCTURE OF AN ARCHAEBACTERIAL DNA POLYMERASE D.TOK. DEPOSITION OF SECOND NATIVE STRUCTURE AT 2.4 ANGSTROM |
>1d5a_A mol:protein length:733 PROTEIN (DNA POLYMERASE)
MILDADYITEDGKPVIRVFKKEKGEFKIDYDRDFEPYIYALLKDDSAIEDIKKITAERHGTTVRVTRAERVKKKFLGRPVEVWKLYFTHPQDVPAIRDKIREHPAVVDIYEYDIPFAKRYLIDRGLIPMEGDEELRMLAFDIETLAHAGAAAGAGPILMISYADEEGARVITWKNIDLPYVESVSTEKEMIKRFLKVIQEKDPDVLITYNGDNFDFAYLKKRSEMLGVKFILGRDGSEPKIQRMGDRFAVEVKGRIHFDLYPVIRRTINLPTYTLETVYEPVFGQPAEKVYAEEIAEAWASGEGLERVARYSMEDAKATYELGKEFFPMEAQLSRLVGQSLWDVSRSSTGNLVEWFLLRKAYERNDVAPNKPDERELARRTESYAGGYVKEPEKGLWENIVYLDYKSLYPSIIITHNVSPDTLNREGCREYDVAPQVGHRFCKDFPGFIPSLLGDLLEERQKVKKKMKATVDPIERKLLDYRQRAIKILANSYYGYYAYANARWYCRECAESVTAWGRQYIETTMREIEEKFGFKVLYADTDGFFATIPGADAETVKNKAKEFLNYINPRLPGLLELEYEGFYRRGFFVTKKKYAVIDEEDKITTRGLEIVRRDWSEIAKETQARVLEAILKHGDVEEAVRIVKEVTEKLSRHEVPPEKLVIYEAGPHVAAAATVISYIVLKGPGRVGDRAIPFDEFDPAKHRYDAEYYIENQVLPAVERILRAFGYRKEDLR |
3856 |
HLA04033 DRB1*15:01:07 |
HLA NFT |
DRB1*15:01:07 |
>HLA:HLA04033 DRB1*15:01:07 89 bp RFLWQPKRECHFFNGTERVRFLDRYFYNQEESVRFDSDVGEFRAVTELGRPDAEYWNSQKDILEQARAAVDTYCRHNYGVVESFTVQRR |
3857 |
HLA04034 DRB1*11:84:01 |
HLA NFT |
DRB1*11:84:01 |
>HLA:HLA04034 DRB1*11:84:01 183 bp RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEFRAVTELGRPDEEYWNSQKDFLEDRRAAVDNYCRHNYGVVESFTVQRRVHPKVTVYPSKTQPLQHHNLLVCSVSGFYPGSIEVRWFRNGQEEKTGVVSTGLIHNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEW |
3857 |
1D5B |
PDB NFT |
UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY |
>1d5b_A mol:protein length:211 chimeric OXY-COPE catalytic ANTIBODY AZ-28 (light chain)
DIKMTQSPSSMYASLGERVTITCKASQDINSYLNWFQQKPGKSPKTLIYRTNRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
>1d5b_L mol:protein length:211 chimeric OXY-COPE catalytic ANTIBODY AZ-28 (light chain)
DIKMTQSPSSMYASLGERVTITCKASQDINSYLNWFQQKPGKSPKTLIYRTNRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
>1d5b_B mol:protein length:221 chimeric OXY-COPE catalytic ANTIBODY AZ-28 (HEAVY chain)
QVQLQQSGAELMKPGASVKISCKATGYTFSSFWIEWVKQRPGHGLEWIGEILPGSGGTHYNEKFKGKATFTADKSSNTAYMQLSSLTSEDSAVYYCARGHSYYFYDGDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK
>1d5b_H mol:protein length:221 chimeric OXY-COPE catalytic ANTIBODY AZ-28 (HEAVY chain)
QVQLQQSGAELMKPGASVKISCKATGYTFSSFWIEWVKQRPGHGLEWIGEILPGSGGTHYNEKFKGKATFTADKSSNTAYMQLSSLTSEDSAVYYCARGHSYYFYDGDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK |
3857 |
O04011 |
AF NFT |
Auxin-binding protein ABP20 |
>sp|O04011|ABP20_PRUPE Auxin-binding protein ABP20 OS=Prunus persica OX=3760 GN=ABP20 PE=2 SV=1 MPQATMIFPILFTFFLLLSSSNAAVQDFCVADLAAPEGPAGFSCKKPASVKVNDFVFSGLGIAGNTSNIIKAAVTPAFVAQFPGVNGLGISIARLDLAVGGVVPFHTHPGASEVLIVAQGTICAGFVASDNTPYLQTLEKGDIMVFPQGLLHFQVNGGEAPALAFASFGSASPGLQILDFALFKNDLPTEVIAQTTFLDAAQIKKLKGVLGGTN |
3858 |
Q27906 |
AF NFT |
Probable antibacterial peptide |
>sp|Q27906|ABP2_RIPCL Probable antibacterial peptide OS=Riptortus clavatus OX=41704 PE=2 SV=1 MHIARFCLLSSMAVLALSAGYVSGAVIEIPDEILDSARFISLYSDGLRQKRQLNLSGPGSEHAGTIRLDGQRNIFDNGRTRVDGTGSYQLDYARGMKPIHGAGLGAEVNHNIWRGRGGQSLDLYGGATRQFNFGNRPNEWGAHGGIRYNF |
3858 |
1D5C |
PDB NFT |
CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM RAB6 COMPLEXED WITH GDP |
>1d5c_A mol:protein length:162 RAB6 GTPASE
KYKLVFLGEQAVGKTSIITRFMYDTFDNNYQSTIGIDFLSKTLYLDEGPVRLQLWDTAGQERFRSLIPSYIRDSAAAIVVYDITNRQSFENTTKWIQDILNERGKDVIIALVGNKTDLGDLRKVTYEEGMQKAQEYNTMFHETSAKAGHNIKVLFKKTASKL |
3858 |
HLA04035 DRB1*04:05:08 |
HLA NFT |
DRB1*04:05:08 |
>HLA:HLA04035 DRB1*04:05:08 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRR |
3859 |
HLA04036 DRB1*04:83 |
HLA NFT |
DRB1*04:83 |
>HLA:HLA04036 DRB1*04:83 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYLQEEYVRFDSDVGEYRAVTELGRPSAEYWNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRR |
3859 |
1D5D |
PDB NFT |
The role of phenylalanine 8 in the stabilization of the s protein-s peptide interaction: packing and cavities |
>1d5d_A mol:protein length:15 S PEPTIDE
KETAAAKMERQHLDS
>1d5d_B mol:protein length:101 RNASE S
NYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDASV |
3859 |
Q9USY4 |
AF NFT |
ARS-binding protein 2 |
>sp|Q9USY4|ABP2_SCHPO ARS-binding protein 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=abp2 PE=1 SV=1 MNFYSLLPSRHDVSADNITEKFCQFCLCCNPWYAGADTRQLANAFNMIPKSEGQKFEIWVLFLLVRQYHQKIINSWSKLVGFLGVERKDEQSTQKIQQYVVRLKRWMSQTHVDAFFDYLLNKPNPYYLEIPETQPQVRCNVNVTDDLVIKSLRAGLMSHPDVNSSSISTMRTSTSPSNWIHSASASLDDNTHNLGSFVTNPHADSQECPTPQSLLMRASHHMSERGSQQAHQTTPQNHSLPHPPNMFEPPDEDHQLPSAANNSHNHDHAFQTAEAVGVADSIDPDWHQWPDDLRDVSSPKESDGLNDSWSRQTNQVETENVENEAGVPRKRGRPPGARNKIKRLRSEPSVSLTLSISWYERFEKLMHAQNTMLRSAFSHVARLPMETVSQLLSHYTETISQYLPPSETSPIPKTPNFKFISSTLLALVSSHSEILEASTDRLIWTVHQGPLTATICHAFNLEKAPSMHSLAEAQMIPDVPISHSNSMEPLDTVSSLKLEIAKLNAALKEKNLELENLKRKIMNAVFD |
3860 |
P33491 |
AF NFT |
Auxin-binding protein T92 |
>sp|P33491|ABP2_TOBAC Auxin-binding protein T92 OS=Nicotiana tabacum OX=4097 GN=T92 PE=3 SV=1 MARHIIILVAVFWFATAEASHCSINGLPLVRNISELPQENYGRSGLSHTTIAGSVLHGMKEIEVWLQTFAPGFRTPIHRHSCEEIFIVLKGQGTLYLTPSSHSKYPGNPQEFHIFPNSTFHIPVNDVHQVWNTGEQEDLQVLDVISRPPVKVFMYDDWSMPHTAAKLKFPYYWDEECYQTTSRKDEL |
3860 |
1D5E |
PDB NFT |
The role of phenylalanine 8 in the stabilization of the S protein-S peptide interaction: Packing and cavities |
>1d5e_A mol:protein length:15 S PEPTIDE
KETAAAKLERQHLDS
>1d5e_B mol:protein length:101 RNASE S
NYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDASV |
3860 |
HLA04037 DRB1*01:23 |
HLA NFT |
DRB1*01:23 |
>HLA:HLA04037 DRB1*01:23 89 bp RFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLEDRRAAVDTYCRHNYGAVESFTVQRR |
3861 |
HLA04038 DRB1*04:06:03 |
HLA NFT |
DRB1*04:06:03 |
>HLA:HLA04038 DRB1*04:06:03 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEESVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLEQRRAEVDTYCRHNYGVVESFTVQRR |
3861 |
1D5F |
PDB NFT |
STRUCTURE OF E6AP: INSIGHTS INTO UBIQUITINATION PATHWAY |
>1d5f_A mol:protein length:358 E6AP HECT CATALYTIC DOMAIN, E3 LIGASE
QLNPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVVEEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYRKLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKENGDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLICGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYAKGFGML
>1d5f_B mol:protein length:358 E6AP HECT CATALYTIC DOMAIN, E3 LIGASE
QLNPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVVEEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYRKLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKENGDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLICGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYAKGFGML
>1d5f_C mol:protein length:358 E6AP HECT CATALYTIC DOMAIN, E3 LIGASE
QLNPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVVEEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYRKLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKENGDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLICGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYAKGFGML |
3861 |
P84994 |
AF NFT |
Villin-like protein ABP41 (Fragments) |
>sp|P84994|ABP41_LILDA Villin-like protein ABP41 (Fragments) OS=Lilium davidii OX=82316 PE=1 SV=1 PAFQGVGQRLGTEIESSKDEAATAALKTVELDAVLGGRTPEEETFETRLYQFNGANSNLQERALEVLQYLKVMGDPTVTLETTPGKSAEEFLLDENRPKDVALLDDGRVVEEETMETRLYQFNGANSNLGAERSAEEMLLNENRPK |
3862 |
P33488 |
AF NFT |
Auxin-binding protein 4 |
>sp|P33488|ABP4_MAIZE Auxin-binding protein 4 OS=Zea mays OX=4577 GN=ABP4 PE=2 SV=1 MVRRRPATGAAPRPHLAAVGRGLLLASVLAAAASSLPVAESSCPRDNSLVRDISRMQQRNYGREGFSHITVTGALAHGTKEVEVWLQTFGPGQRTPIHRHSCEEVFIVLKGKGTLLLGSSSLKYPGQPQEVPVFQNTTFSIPVNDPHQVWNSNEHEDLQVLVIISRPPVKIFIYDDWSMPHTAAKLKFPYFWDEDCLPAPKDEL |
3862 |
1D5G |
PDB NFT |
SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE |
>1d5g_A mol:protein length:96 HUMAN PHOSPHATASE HPTP1E
PKPGDIFEVELAKNDNSLGISVTGGVNTSVRHGGIYVKAVIPQGAAESDGRIHKGDRVLAVNGVSLEGATHKQAVETLRNTGQVVHLLLEKGQSPT
>1d5g_B mol:protein length:15 PEPTIDE FADSEADENEQVSAV
FADSEADENEQVSAV |
3862 |
HLA04039 DRB1*04:04:02 |
HLA NFT |
DRB1*04:04:02 |
>HLA:HLA04039 DRB1*04:04:02 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLEQRRAAVDTYCRHNYGVVESFTVQRR |
3863 |
HLA04040 DRB1*04:84 |
HLA NFT |
DRB1*04:84 |
>HLA:HLA04040 DRB1*04:84 89 bp RFLEQVKHECHFFNGTERVRFLDRYFYHQEESVRFDSDVGEYRAVTELGRPSAEYWNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRR |
3863 |
1D5H |
PDB NFT |
Rnase s(f8a). mutant ribonucleasE S. |
>1d5h_A mol:protein length:15 S PEPTIDE
KETAAAKAERQHMDS
>1d5h_B mol:protein length:101 RNASE S
NYCNQMMKSRNLTKDRCKPVNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDCRETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDASV |
3863 |
P33489 |
AF NFT |
Auxin-binding protein 5 (Fragment) |
>sp|P33489|ABP5_MAIZE Auxin-binding protein 5 (Fragment) OS=Zea mays OX=4577 GN=ABP5 PE=3 SV=1 MVRRRPATGAAQRPQLAAVGRGLLLASVLAAAASSLPVAESSCPRDNSLVRDISRMQQSNYGREGFSHITVTGALAHGTKEVEVWLQTFGPGQRTPIHRHSCEEVFIVLKGKGTLLLGSSSLKYPGQPQEVPVFQNTTFSIPVNDPHQVW |
3864 |
Q54ET6 |
AF NFT |
Actin-binding protein F |
>sp|Q54ET6|ABPF_DICDI Actin-binding protein F OS=Dictyostelium discoideum OX=44689 GN=abpF PE=1 SV=1 MTVSNNKKFEENYVLASDIEEKEKLLGTLIGGSPQYFYYNVIHLLNVDPTLSDSKNREKYQKLMKDWSPESKPIPVTPYGGNNNYESTQQYKSVDLRQKLLSFRQDNVNPSALANNVNDMFEELRYLLSLTFSYTQTTHQTSPTTETTTTPSSSSSSSHDDKSESTLDESLVNKKTVIESIINQYPYKVDYISPNSFEYVLNNFTLPESAEKSIVQKLKYPIVPNDKLQQLLSHHKGSFGSLKIHENLTLEQMEKHIEKNPEHLDSAYVKLYLEKLLPTNELHDWETLKPVQEQFYQSASKFVSNLPTSLNTFKLLIYHHYIKFQISDNKYDQSIIEKYFQLPRDTYYYVEPDRLKSNPQLSKFNDSFNGLKSVSQDDDEKLISFLLKKLFLKENSIKSYQSYFRPNYLNLILAESKLLSNDSSPEKWIEMIDNHTKVQELKDRVDIEFLPTNREYYHPDDDVVIECAIKNVNTLLVKVFEISTFNYYKSENKKIDSNINLDGLIASQELSFDYSEQAPIEKVEKKFDFPNLKGKRGIFVIEFIGNGKSSRSMIQKGDLHFIVETSPIGQVIKIIDQDSIKVQKSSVYIDGNAYNSNDDGDIKIPFSSSTSQKSIILMAKIGDSDVFASLKKFTHQSEHYSLSGGIFVENSSLLQNEKAPIVVRVKLFLGDTQISNNYLEEPSLTITSSDNSESPVVNSKEIKPFALFDNKESVYQYKVQEGLNSLTVRFEAKVRALSRNNNQETLSFESTFQVNTINQTDQISEFYLERCLAKDGCSLGYQLCHLGKGGDPFSHLDVSMDFQHWLTSERIYTTLKTDKNGKIHLGSLADIEQLNVNGSYATFNFPIKRQQQFTYPSQINIKLGETIRLPYLGNEKSVSHSQINFFQLGGVDDRNFVVHDLLKKSVTIENKNELLINGLGVGRYLLILAGSIQSSNTVEILIDVVDGQFREGYLVGPSRIVSYNESNVKSLFFDTNIDTKHNQLQVKFKNHSPSTRVHVFSSYFEPTNSLNSSLSLSRGTSQSYQEYSVKPKSLYFNGRSLGDEVNYILNRKTSKKLLPGNSLKKPSLLVQPWSIGKTTNSTNTLKQASKYNESEVKDEKSMRNRQVEKRRVSSTNRSPFLEFLSHPSILLLNLEPSSTDGIVNIDLSQLVEAGSTIHIHAVDNDSIFTKEIVISDPSSSSSINHFKDTKLVRPLDSSLHYKEEKLITTVEPNSPFEILNVNSSKYTVYDSLDKVLSLMKTLNKSYLQDFSFIAEWESLSFEKKKEKFSKFTCHELNFFIYKKDKEFFDQVVLPLVQTKGYKTFIDHYLCADRKKLEIFVIDSNRFNTLNALEMVLLGELFPEHSDSISNLLKQKVGFSPISPSQYDTNFKIALNQLDTDIESLKSGDDDLYDDGSNLEPMSVGGGGGFGYNNNSNNNNNTTNSNSFGDAKRAPMKKKMVNKESTSLMMDCAAPMMMMASAPCPAPGAVPMAALRSARLASASPAPPAPITRAYEAAQIYQPIEKTEELAETYYYKQLNPHSSLIPVNEFWLDYANHIKSQSKTPFVSKYIAFISSSFAESMMALSVLDFPFTVKDNTTQVRPKNGKLSMKPTTPIVVFHQELVSGSIEKQSDILVTQHFFDPQNQFTYIDGEQEELYINDQFLVSKVYGAMVVIANLSSKQKKLDALLEIPKGSIAVGPSPFVTRSKSVNLSAYSTTRLQYYFYFPEAGKFPHFPAHVSEKQNIIANVTPFTFSVVLKPSIVNHLSWEYIANQGTLESILEYLSKNNLYRVDFYHLYHRYTDKKVWDKVIELLKKLKFYESITWSFSIHHKNFVYLKDYLSEQIHSLSMKSIDAPSIYVDPFENNFIKFLEYSPLVNSRTHQIGDERKILNNKLSNQYYEFCSLLSLKLNPSDTELLSLAYYLLLQDRFDESIKIMKRIGKHPVSIPKLISSSTTTDSKSTHSSVISSSSSSNLSTTTDSSKDKKKLEKEEKQREKERKQKEKEDKKREKEELKKKEKEEKKKKEEEKKLKKKSGSEATSPSVDPATPTTTTTTEATTTTTTTTATSQESIKPEKIASDDEHDDHHHDEHDEEDDDDEPLIDMSEFNQPSCLPEMKVQYDYLLSYLDFFNPNPTVAAENSKKYENYPVQRWNSLFKDLRNKVDQVSNKDSVEIDYEKEIDRERRQNKMASNEPTFDISSESNRTISVNYSNLVDITVSYYVMDIEHLFSTNPFVQQELGHFLYVTPNKKESFLLKDKSGTFNFKIPNEFANSNVVIDVVSAQIHHNITVYSNNLAVYITEKVGQLRVVHKQKSQPISKTYIKVYSKNKNGSVEFFKDGYTDIAGYFDYSTVSSLDISNVSKLSILVLSNQYGAVIKEAKPPGF |
3864 |
1D5I |
PDB NFT |
UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY |
>1d5i_L mol:protein length:211 CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN)
DIKMTQSPSSMYASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR
>1d5i_H mol:protein length:221 CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN)
QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARGHSYYFYDGDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK |
3864 |
HLA04041 B*39:01:07 |
HLA NFT |
B*39:01:07 |
>HLA:HLA04041 B*39:01:07 181 bp SHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQICKTNTQTDRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHNQFAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRTYLEGTCVEWLRRYLENGKETLQRA |
3865 |
HLA04042 B*07:02:12 |
HLA NFT |
B*07:02:12 |
>HLA:HLA04042 B*07:02:12 181 bp SHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHDQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGECVEWLRRYLENGKDKLERA |
3865 |
1D5J |
PDB NFT |
CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR. |
>1d5j_A mol:protein length:173 STROMELYSIN-1
FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET
>1d5j_B mol:protein length:173 STROMELYSIN-1
FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPET |
3865 |
Q0PGP2 |
AF NFT |
Androgen-binding protein homolog |
>sp|Q0PGP2|ABP_MESAU Androgen-binding protein homolog OS=Mesocricetus auratus OX=10036 PE=3 SV=1 MKGTLLLLALLVTGELGFQTTEACIPFYEAFGAVVLGNKQVLDVVLSKFNATDKEREAFEKIQECYNDGGLKSKLLDTRVVYEVTVNSPCKEYYTKDTILKVEDLLFQIQRHIMG |
3866 |
B2FKA7 |
AF NFT |
Actin-binding protein Smlt3054 |
>sp|B2FKA7|ABP_STRMK Actin-binding protein Smlt3054 OS=Stenotrophomonas maltophilia (strain K279a) OX=522373 GN=Smlt3054 PE=1 SV=1 MEMDIQESLLRLLRPLGLQRAEALAGALAREAGASKGLHDSQVLARAHALSVAPVEGRLGDLVWQVRQREHDGAPQVDLRWGLHRLGLDAPSRASTRDLVRAYERRLADRNEPMVYSTLAERVAGSMAEHTSLFQGMAMAVEEARARRSDANRLRENAPWQGWLVGASRAGHEAALLACIGMGADARLPDASGNTPLHHAARFGHFSLVTPLVEAGADVAALNAHGWAPLHLAALHKHARACLHLMAHGANPEQPGWRGRTPTRMHRHEQTQAL |
3866 |
1D5L |
PDB NFT |
CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5 |
>1d5l_A mol:protein length:104 MYELOPEROXIDASE
CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPA
>1d5l_B mol:protein length:104 MYELOPEROXIDASE
CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPA
>1d5l_C mol:protein length:466 MYELOPEROXIDASE
VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA
>1d5l_D mol:protein length:466 MYELOPEROXIDASE
VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA |
3866 |
HLA04043 B*39:01:08 |
HLA NFT |
B*39:01:08 |
>HLA:HLA04043 B*39:01:08 181 bp SHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQICKTNTQTDRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHNQFAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRTYLEGTCVEWLRRYLENGKETLQRA |
3867 |
HLA04044 B*44:75 |
HLA NFT |
B*44:75 |
>HLA:HLA04044 B*44:75 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRNLRGYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQDRAYLEGLCVESLRRYLENGKETLQRA |
3867 |
1D5M |
PDB NFT |
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB |
>1d5m_A mol:protein length:181 HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFD
>1d5m_B mol:protein length:192 HLA CLASS II HISTOCOMPATIBILITY ANTIGEN
GDTRPRFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLEQKRAAVDTYCRHNYGVGESFTVQRRVYPEVTVYPAKTQPLQHHNLLVCSVNGFYPGSIEVRWFRNGQEEKTGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRARS
>1d5m_C mol:protein length:239 ENTEROTOXIN TYPE B
ESQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGNYDNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKTNDINSHQTDKRKTCMYGGVTEHNGNQLDKYRSITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNSPYETGYIKFIENENSFWYDMMPAPGDKFDQSKYLMMYNDNKMVDSKDVKIEVYLTTKKK
>1d5m_D mol:protein length:9 INHIBITOR
XARAMCSLX |